ADVERTISEMENT
search.svg

CEO Blog: Scott Knoer, MS, PharmD, FASHP

Scott Knoer is the 13th executive vice president and CEO of the American Pharmacists Association. Before joining APhA in 2020, Scott served as Chief Pharmacy Officer for the Cleveland Clinic. He also served in pharmacy leadership roles at the University of Minnesota Medical Center, Fairview, and the University of Texas Medical Branch at Galveston.

Read more about Scott

Workplace conditions and well-being

Workplace conditions and well-being

We hear you! Your pharmacy workplace is stressed and stretched. You have rapidly growing concerns for patient safety. Still, you are there—every day—to care for your patients despite conditions that seem to be working against you.

The federal government needs drug price solutions. We’ve got their back.

The federal government needs drug price solutions. We’ve got their back.

Earlier this month, HHS was working on an aggressive deadline. President Joe Biden had given them 45 days to develop a comprehensive plan to lower drug prices, and the clock was ticking. HHS asked stakeholders across the spectrum to provide input during a special roundtable discussion. Guess who they called from pharmacy?

Calling balls and strikes on PBMs—and the other players, too

Calling balls and strikes on PBMs—and the other players, too

It should be abundantly clear that APhA has several bones to pick with big pharmacy benefit managers (PBMs). These PBMs, operating under the guise of altruism, paint themselves as saints who work to lower prescription drug prices for the masses. Instead, they actively game the system by knocking out pharmacy competitors, reducing patient access to medicines and pharmacist services, and ripping off patients, employers, and taxpayers.

RSS